Gemcitabine-radiotherapy in patients with locally advanced pancreatic cancer.
about
A current perspective on stereotactic body radiation therapy for pancreatic cancerThe relation between deoxycytidine kinase activity and the radiosensitising effect of gemcitabine in eight different human tumour cell linesInhibition of RAC1 GTPase sensitizes pancreatic cancer cells to γ-irradiation.A phase 2 trial of gemcitabine, 5-fluorouracil, and radiation therapy in locally advanced nonmetastatic pancreatic adenocarcinoma : cancer and Leukemia Group B (CALGB) 80003.Phase II trial of selective internal radiation therapy and systemic chemotherapy for liver-predominant metastases from pancreatic adenocarcinoma.Concurrent radiotherapy with oral fluoropyrimidine versus gemcitabine in locally advanced pancreatic cancer: a systematic review and meta-analysis.Multidisciplinary neoadjuvant management for potentially curable pancreatic cancer.Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial.Weekly full-dose gemcitabine and single-dose cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer.Phase-I trial of oral fluoropyrimidine anticancer agent (S-1) with concurrent radiotherapy in patients with unresectable pancreatic cancer.Predictive dosimetric parameters for gastrointestinal toxicity with hypofractioned radiotherapy in pancreatic adenocarcinoma.Stereotactic Body Radiation Therapy (SBRT) for Unresectable Pancreatic Carcinoma.Discovery and characterization of small molecule Rac1 inhibitorsLocally advanced pancreatic cancer treated with radiation and 5-fluorouracil: a first step to neoadjuvant treatment?Safety of selective internal radiation therapy (SIRT) with yttrium-90 microspheres combined with systemic anticancer agents: expert consensus.
P2860
Q28077111-6229AD3B-5151-4D5F-846E-3774581C127EQ33245149-BF8DE26D-FAC5-48C4-AD52-C366E41D9FF7Q34786416-78485D5B-EACF-40FA-B17B-90F447F7E3CBQ35050606-304F8804-F66C-437A-8973-8CD772984867Q35822196-1AF95E93-4ADD-4D71-AAAB-4BDDF4740239Q35860668-55A4EBB5-D622-4AD6-A695-A025AAAE7266Q36023889-6EE0480F-E1DA-4563-BA0B-DA1F12515417Q36476666-ECF04563-3C09-475F-8BE3-6E69CEFEDA85Q36494203-991FCA7A-D093-4144-8334-E643C18B8888Q36610363-3AD828BA-CE47-42FC-841A-F05A93CD4090Q36858211-FCFAD518-7E14-46BD-BCBB-4232D7A4E18BQ42079167-30F4340E-AE38-4144-B439-99C2BB65A68FQ42117338-DF5ACD75-0520-437F-8364-7B43ABBA892BQ46683157-B32ED8EF-1F6C-4E7D-A862-E69FEE29047BQ47134709-72B1DAD2-A2B9-4C92-9C92-C27B20CC3AF6
P2860
Gemcitabine-radiotherapy in patients with locally advanced pancreatic cancer.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Gemcitabine-radiotherapy in patients with locally advanced pancreatic cancer.
@ast
Gemcitabine-radiotherapy in patients with locally advanced pancreatic cancer.
@en
type
label
Gemcitabine-radiotherapy in patients with locally advanced pancreatic cancer.
@ast
Gemcitabine-radiotherapy in patients with locally advanced pancreatic cancer.
@en
prefLabel
Gemcitabine-radiotherapy in patients with locally advanced pancreatic cancer.
@ast
Gemcitabine-radiotherapy in patients with locally advanced pancreatic cancer.
@en
P2093
P1476
Gemcitabine-radiotherapy in patients with locally advanced pancreatic cancer
@en
P2093
C J van Groeningen
G J Peters
H M Pinedo
J A Langendijk
J M G H van Riel
M A Cuesta
O W M Meijer
S M de Lange
P304
P356
10.1016/S0959-8049(02)00076-X
P577
2002-06-01T00:00:00Z